Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Int J Mol Sci ; 25(8)2024 Apr 13.
Artigo em Inglês | MEDLINE | ID: mdl-38673889

RESUMO

Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer. The incidence of metastasis for cSCC is estimated to be around 1.2-5%. Ribosomal protein S6 (p-S6) and the p21 protein (p21) are two proteins that play central roles in other cancers. These proteins may be equally important in cSCC, and together, these could constitute a good candidate for metastasis risk assessment of these patients. We investigate the relationship of p-S6 and p21 expression with the impact on the prognosis of head and neck cSCC (cSCCHN). p-S6 and p21 expression was analyzed by immunohistochemistry on paraffin-embedded tissue samples from 116 patients with cSCCHN and associations sought with clinical characteristics. Kaplan-Meier estimators and Cox proportional hazard regression models were also used. The expression of p-S6 was significantly inversely associated with tumor thickness, tumor size, desmoplastic growth, pathological stage, perineural invasion and tumor buds. p21 expression was significantly inversely correlated with >6 mm tumor thickness, desmoplastic growth, and perineural invasion. p-S6-negative expression significantly predicted an increased risk of nodal metastasis (HR = 2.63, 95% CI 1.51-4.54; p < 0.001). p21 expression was not found to be a significant risk factor for nodal metastasis. These findings demonstrate that p-S6-negative expression is an independent predictor of nodal metastasis. The immunohistochemical expression of p-S6 might aid in better risk stratification and management of patients with cSCCHN.


Assuntos
Neoplasias de Cabeça e Pescoço , Metástase Linfática , Neoplasias Cutâneas , Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Neoplasias Cutâneas/patologia , Neoplasias Cutâneas/metabolismo , Neoplasias de Cabeça e Pescoço/patologia , Neoplasias de Cabeça e Pescoço/metabolismo , Inibidor de Quinase Dependente de Ciclina p21/metabolismo , Prognóstico , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/patologia , Idoso de 80 Anos ou mais , Biomarcadores Tumorais/metabolismo , Carcinoma de Células Escamosas de Cabeça e Pescoço/metabolismo , Carcinoma de Células Escamosas de Cabeça e Pescoço/patologia , Adulto , Estimativa de Kaplan-Meier , Modelos de Riscos Proporcionais , Imuno-Histoquímica
2.
Cancers (Basel) ; 15(16)2023 Aug 17.
Artigo em Inglês | MEDLINE | ID: mdl-37627180

RESUMO

Waldenström Macroglobulinemia (WM) is a lymphoplasmacytic lymphoma with bone marrow (BM) involvement and IgM monoclonal gammopathy. To date, no studies have focused specifically on peripheral blood (PB) involvement. In this study, 100 patients diagnosed with WM according to the World Health Organization (WHO) criteria were included based on the demonstration of MYD88mut in BM and the availability of PB multiparametric flow cytometry (MFC) analysis. Leukemic involvement by MFC was detected in 50/100 patients. A low percentage of mature small lymphocytes in PB smears was observed in only 15 cases. MYD88mut by AS-qPCR was detected in PB in 65/100 cases. In cases with leukemic expression by MFC, MYD88mut was detected in all cases, and IGH was rearranged in 44/49 cases. In 21/50 patients without PB involvement by MFC, molecular data were consistent with circulating disease (MYD88mut by AS-qPCR 3/50, IGH rearranged 6/50, both 12/50). Therefore, PB involvement by standard techniques was detected in 71/100 patients. MYD88mut was detected in PB by dPCR in 9/29 triple negative cases. Overall, 80% of the patients presented PB involvement by any technique. Our findings support the role of PB MFC in the evaluation of patients with IgM monoclonal gammopathy and provide reliable information on correlation with molecular features. The development of a feasible MFC assay may stand as an objective tool in the classification of mature B cell neoplasms presenting with IgM monoclonal gammopathy.

3.
J Dermatolog Treat ; 28(8): 726-730, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28489469

RESUMO

PURPOSE: Psoriasis patients have high risk of atherosclerosis, characterized by endothelial dysfunction. We aimed to study the association of the endothelial activation biomarkers monocyte chemoattractant protein 1 (MCP-1), soluble (s) E-selectin and P-selectin with disease activity and severity in psoriasis patients treated with anti-TNF-α therapy. Also, to evaluate the relationship of metabolic syndrome features with these biomarkers and the effect of anti-TNF-α therapy on these molecules. METHODS: Twenty-nine consecutive non-diabetic patients with moderate-to-severe psoriasis who underwent 6 months of anti-TNF-α-adalimumab therapy were studied. Metabolic and clinical evaluation was performed prior to anti-TNF-α treatment (time 0) and 6 months later. MCP-1, sE-selectin and sP-selectin serum levels were determined by ELISA. RESULTS: Dyslipidemic and obese patients showed higher MCP-1 levels at month 6 from the onset of anti-TNF-α therapy (p = .05 and .01, respectively). sE-selectin positively correlated with pro-inflammatory molecules such as asymmetric dimethylarginine, sP-selectin and resistin at baseline and month 6 (p < .05). sE-selectin levels significantly reduced after 6 months of therapy (p = .0006). CONCLUSIONS: Metabolic syndrome features are associated with endothelial activation in patients with moderate-to-severe psoriasis. Adalimumab therapy led to a reduction in sE-selectin levels, supporting the beneficial effect of anti-TNF-α therapy on mechanisms associated with the development of atherosclerosis in psoriasis.


Assuntos
Adalimumab/uso terapêutico , Selectina E/sangue , Psoríase/tratamento farmacológico , Adulto , Biomarcadores/sangue , Quimiocina CCL2/sangue , Dislipidemias/complicações , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Imunoterapia , Masculino , Pessoa de Meia-Idade , Obesidade/complicações , Selectina-P/sangue , Psoríase/complicações , Psoríase/patologia , Resistina/sangue , Índice de Gravidade de Doença , Fator de Necrose Tumoral alfa/imunologia
4.
J Invest Dermatol ; 137(1): 197-206, 2017 01.
Artigo em Inglês | MEDLINE | ID: mdl-27592799

RESUMO

Merkel cell carcinoma (MCC) is a highly malignant neuroendocrine tumor of the skin whose molecular pathogenesis is not completely understood, despite the role that Merkel cell polyomavirus can play in 55-90% of cases. To study potential mechanisms driving this disease in clinically characterized cases, we searched for somatic mutations using whole-exome sequencing, and extrapolated our findings to study functional biomarkers reporting on the activity of the mutated pathways. Confirming previous results, Merkel cell polyomavirus-negative tumors had higher mutational loads with UV signatures and more frequent mutations in TP53 and RB compared with their Merkel cell polyomavirus-positive counterparts. Despite important genetic differences, the two Merkel cell carcinoma etiologies both exhibited nuclear accumulation of oncogenic transcription factors such as NFAT or nuclear factor of activated T cells (NFAT), P-CREB, and P-STAT3, indicating commonly deregulated pathogenic mechanisms with the potential to serve as targets for therapy. A multivariable analysis identified phosphorylated CRE-binding protein as an independent survival factor with respect to clinical variables and Merkel cell polyomavirus status in our cohort of Merkel cell carcinoma patients.


Assuntos
Biomarcadores Tumorais/genética , Carcinoma de Célula de Merkel/genética , Carcinoma de Célula de Merkel/virologia , Poliomavírus das Células de Merkel/genética , Neoplasias Cutâneas/genética , Neoplasias Cutâneas/virologia , Idoso , Idoso de 80 Anos ou mais , Biópsia por Agulha , Carcinogênese/genética , Carcinoma de Célula de Merkel/mortalidade , Carcinoma de Célula de Merkel/patologia , Estudos de Coortes , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , Imuno-Histoquímica , Masculino , Poliomavírus das Células de Merkel/isolamento & purificação , Análise Multivariada , Mutação , Oncogenes/genética , Prognóstico , Medição de Risco , Transdução de Sinais/genética , Neoplasias Cutâneas/mortalidade , Neoplasias Cutâneas/patologia , Análise de Sobrevida , Proteína Supressora de Tumor p53/genética , Proteína Supressora de Tumor p53/metabolismo , Infecções Tumorais por Vírus/mortalidade , Infecções Tumorais por Vírus/patologia , Raios Ultravioleta/efeitos adversos
5.
An R Acad Nac Med (Madr) ; 119(2): 367-80; discussion 380-9, 2002.
Artigo em Espanhol | MEDLINE | ID: mdl-12518660

RESUMO

After revising some of the most important migratory phenomenons that have been along history, the subject is based on increase of feminine immigration, in the same way that in principal responsible causes of the matter. The most important sanitary problems are studied. Firstly, the common problems with men: increase of tuberculosis, of AIDS, of sexual transmissión illness and parasitosis, inside transmissible processes, in the same way that psychological processes. Secondly, the specific women problems, concerning with the maternity, the delivery, the prostitution, and other problems less frequent as the ablation, the lack of communication, etc. Equally, possible solutions are expounded, always contemplating the three essential aspects: political, social and sanitary actions.


Assuntos
Emigração e Imigração/tendências , Migrantes/psicologia , Síndrome da Imunodeficiência Adquirida/epidemiologia , Circuncisão Feminina/tendências , Feminino , Hepatite B/epidemiologia , Hepatite C/epidemiologia , Humanos , Incidência , Neisseria meningitidis/patogenicidade , Doenças Parasitárias/epidemiologia , Política , Gravidez , Trabalho Sexual/estatística & dados numéricos , Infecções Sexualmente Transmissíveis/epidemiologia , Mudança Social , Espanha/epidemiologia , Tuberculose/epidemiologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa